Subtype
Pilocytic Astrocytoma
CI-CAN-00008240Explore in graph →
Non-malignant5 active trials10 evidence items
Loading cancer entity…
Subtype
CI-CAN-00008240Explore in graph →
Clinical trials
21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02186509 | Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas | completed | Phase 1 | 17 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT01119599 | RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00112736 | Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma | completed | Phase 1 / Phase 2 | 69 | National Cancer Institute (NCI)NIH | 1 | Jun 15, 2015 | clinicaltrials |
| NCT00030498 |
Data updated 22 days agoSource updated Apr 30, 2025source: clinicaltrials
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
| completed |
| Phase 1 |
| 75 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Jan 16, 2013 |
| clinicaltrials |